Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation.

Although hepatic encephalopathy (HE) is linked to the gut microbiota, stool microbiome analysis has not found differences between HE and no-HE patients. This study aimed to compare sigmoid mucosal microbiome of cirrhotic patients to controls, between HE vs. no-HE patients, and to study their linkage with cognition and inflammation. Sixty cirrhotic patients (36 HE and 24 no-HE) underwent cognitive testing, stool collection, cytokine (Th1, Th2, Th17, and innate immunity), and endotoxin analysis. Thirty-six patients (19 HE and 17 no-HE) and 17 age-matched controls underwent sigmoid biopsies. Multitag pyrosequencing (including autochthonous genera, i.e., Blautia, Roseburia, Fecalibacterium, Dorea) was performed on stool and mucosa. Stool and mucosal microbiome differences within/between groups and correlation network analyses were performed. Controls had significantly higher autochthonous and lower pathogenic genera compared with cirrhotic patients, especially HE patients. HE patients had worse MELD (model for end-stage liver disease) score and cognition and higher IL-6 and endotoxin than no-HE. Mucosal microbiota was different from stool within both HE/no-HE groups. Between HE/no-HE patients, there was no difference in stool microbiota but mucosal microbiome was different with lower Roseburia and higher Enterococcus, Veillonella, Megasphaera, and Burkholderia abundance in HE. On network analysis, autochthonous genera (Blautia, Fecalibacterium, Roseburia, and Dorea) were associated with good cognition and decreased inflammation in both HE/no-HE, whereas genera overrepresented in HE (Enterococcus, Megasphaera, and Burkholderia) were linked to poor cognition and inflammation. Sigmoid mucosal microbiome differs significantly from stool microbiome in cirrhosis. Cirrhotic, especially HE, patients' mucosal microbiota is significantly different from controls with a lack of potentially beneficial autochthonous and overgrowth of potentially pathogenic genera, which are associated with poor cognition and inflammation.

[1]  H. Rangwala,et al.  Colonic microbiome is altered in alcoholism. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[2]  S. Taylor-Robinson,et al.  A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy , 2012, Metabolic Brain Disease.

[3]  L. Tang,et al.  Comparison of the Gut Microbe Profiles and Numbers Between Patients with Liver Cirrhosis and Healthy Individuals , 2012, Current Microbiology.

[4]  P. Hylemon,et al.  116 THE GUT MICROBIOME MODULATES FECAL BILE ACID PROFILE IN PATIENTS WITH CIRRHOSIS , 2012 .

[5]  C. Hofmann,et al.  Intestinal bacterial translocation in rats with cirrhosis is related to compromised paneth cell antimicrobial host defense , 2012, Hepatology.

[6]  E. Tsianos,et al.  Rifaximin reduces endotoxemia and improves liver function and disease severity in patients with decompensated cirrhosis , 2012, Hepatology.

[7]  P. Hylemon,et al.  Linkage of gut microbiome with cognition in hepatic encephalopathy. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[8]  Tomomi Ikeda,et al.  Effects of Bifidobacterium breve on inflammatory gene expression in neonatal and weaning rat intestine , 2012, Pediatric Research.

[9]  K. Verbeke,et al.  Functional analysis of colonic bacterial metabolism: relevant to health? , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[10]  Baoli Zhu,et al.  Characterization of fecal microbial communities in patients with liver cirrhosis , 2011, Hepatology.

[11]  C. Huttenhower,et al.  Metagenomic biomarker discovery and explanation , 2011, Genome Biology.

[12]  G. Molin,et al.  Gut Microbiota and Inflammation , 2011, Nutrients.

[13]  J. Córdoba,et al.  New assessment of hepatic encephalopathy. , 2011, Journal of hepatology.

[14]  G. Auzinger,et al.  Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis. , 2011, Journal of Hepatology.

[15]  G. Nava,et al.  Diversity of the autochthonous colonic microbiota , 2011, Gut microbes.

[16]  F. Powrie,et al.  The Gut's Clostridium Cocktail , 2011, Science.

[17]  K. Honda,et al.  Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species , 2011, Science.

[18]  D. Harnois.  Rifaximin Improves Driving Simulator Performance in a Randomized Trial of Patients With Minimal Hepatic Encephalopathy , 2011 .

[19]  M. Hussain,et al.  Severity of the compensatory anti-inflammatory response determined by monocyte HLA-DR expression may assist outcome prediction in cirrhosis , 2011, Intensive Care Medicine.

[20]  M. Merli,et al.  Cirrhotic patients are at risk for health care-associated bacterial infections. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[21]  F. Powrie,et al.  Interleukin-23 Drives Intestinal Inflammation through Direct Activity on T Cells , 2010, Immunity.

[22]  R. Flavell,et al.  Checks and balances: IL-23 in the intestine. , 2010, Immunity.

[23]  M. D’Elios,et al.  Targeting IL-23 in human diseases , 2010, Expert opinion on therapeutic targets.

[24]  P. Brigidi,et al.  Through Ageing, and Beyond: Gut Microbiota and Inflammatory Status in Seniors and Centenarians , 2010, PloS one.

[25]  A. Keshavarzian,et al.  Quantitative Assessment of the Human Gut Microbiome Using Multitag Pyrosequencing , 2010, Chemistry & biodiversity.

[26]  A. Gasbarrini,et al.  Intestinal Permeability in Cirrhotic Patients With and Without Spontaneous Bacterial Peritonitis: Is the Ring Closed? , 2010, The American Journal of Gastroenterology.

[27]  M. Merli,et al.  Peripheral and Splanchnic Indole and Oxindole Levels in Cirrhotic Patients: A Study on the Pathophysiology of Hepatic Encephalopathy , 2010, The American Journal of Gastroenterology.

[28]  Marcus J. Claesson,et al.  The Bifidobacterium dentium Bd1 Genome Sequence Reflects Its Genetic Adaptation to the Human Oral Cavity , 2009, PLoS genetics.

[29]  Harry J. Flint,et al.  Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. , 2009, FEMS microbiology letters.

[30]  Mihai Pop,et al.  Statistical Methods for Detecting Differentially Abundant Features in Clinical Metagenomic Samples , 2009, PLoS Comput. Biol..

[31]  Thomas A Hammeke,et al.  Inhibitory control test for the diagnosis of minimal hepatic encephalopathy. , 2008, Gastroenterology.

[32]  J. Doré,et al.  Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients , 2008, Proceedings of the National Academy of Sciences.

[33]  A. Velcich,et al.  The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria , 2008, Proceedings of the National Academy of Sciences.

[34]  Harry Sokol,et al.  Analysis of bacterial bowel communities of IBD patients: What has it revealed? , 2008, Inflammatory bowel diseases.

[35]  E. Bayer,et al.  Plant Cell Wall Breakdown by Anaerobic Microorganisms from the Mammalian Digestive Tract , 2008, Annals of the New York Academy of Sciences.

[36]  P. Tandon,et al.  Bacterial infections, sepsis, and multiorgan failure in cirrhosis. , 2008, Seminars in liver disease.

[37]  R. Jalan,et al.  Role of ammonia and inflammation in minimal hepatic encephalopathy , 2007, Metabolic Brain Disease.

[38]  A. Fernández,et al.  Tablas de normalidad de la población española para los tests psicométricos utilizados en el diagnóstico de la encefalopatía hepática mínima , 2006 .

[39]  L. Eckmann,et al.  How bile acids confer gut mucosal protection against bacteria. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[40]  S. Kliewer,et al.  Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Sanderson,et al.  Molecular characterization of the bacteria adherent to human colorectal mucosa , 2006, Journal of applied microbiology.

[42]  V. Felipo,et al.  [Normality tables in the Spanish population for psychometric tests used in the diagnosis of minimal hepatic encephalopathy]. , 2006, Medicina clinica.

[43]  R. Knight,et al.  UniFrac: a New Phylogenetic Method for Comparing Microbial Communities , 2005, Applied and Environmental Microbiology.

[44]  P. Hylemon,et al.  Development of methods for the detection and quantification of 7alpha-dehydroxylating clostridia, Desulfovibrio vulgaris, Methanobrevibacter smithii, and Lactobacillus plantarum in human feces. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[45]  J. Doré,et al.  Biodiversity of the Mucosa‐Associated Microbiota Is Stable Along the Distal Digestive Tract in Healthy Individuals and Patients With Ibd , 2005, Inflammatory bowel diseases.

[46]  J. Hoefs,et al.  Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club , 2005, Gut.

[47]  R. Wiest,et al.  Bacterial translocation (BT) in cirrhosis , 2005, Hepatology.

[48]  B. Flourié,et al.  Lactulose ingestion increases faecal bifidobacterial counts: A randomised double-blind study in healthy humans , 2004, European Journal of Clinical Nutrition.

[49]  H. Figulla,et al.  Elevated Serum Levels of Astroglial S100β in Patients with Liver Cirrhosis Indicate Early and Subclinical Portal-Systemic Encephalopathy , 1999, Metabolic Brain Disease.

[50]  E. Zoetendal,et al.  Mucosa-Associated Bacteria in the Human Gastrointestinal Tract Are Uniformly Distributed along the Colon and Differ from the Community Recovered from Feces , 2002, Applied and Environmental Microbiology.

[51]  K Weissenborn,et al.  Neuropsychological characterization of hepatic encephalopathy. , 2001, Journal of hepatology.

[52]  T. Therneau,et al.  A model to predict survival in patients with end‐stage liver disease , 2001 .

[53]  H. Flint,et al.  Phylogenetic Relationships of Butyrate-Producing Bacteria from the Human Gut , 2000, Applied and Environmental Microbiology.

[54]  D. Lane.  16S/23S rRNA sequencing , 1991 .

[55]  I. Jolliffe.  Principal Component Analysis , 2002, International Encyclopedia of Statistical Science.

[56]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.